Pharmafile Logo
Pharmafocus logo
Advanced Search

generics

Showing 15 posts of 209 posts found.

GSK boosts stake in Aspen

May 12, 2009
Sales and Marketing GSK, generics

GlaxoSmithKline has extended its stake in the South African generics company Aspen to a 16% shareholding. In return it will …

News

Biosimilars: time for an approval pathway in the US

March 23, 2009
Research and Development, Sales and Marketing US, generics

Congress has received another bill seeking to establish a biosimilars approval pathway in the US. HR 1427 represents the latest …

News

Biosimilars bill offers 12 years’ marketing exclusivity

March 19, 2009
Research and Development US, generics

The US moved one step closer to creating a market for biosimilars – substitutable versions of branded biologic drugs – …

News

Pfizer expands product deal with Indian generic company

March 5, 2009
Sales and Marketing Asia, India, Pfizer, generics

Pfizer has linked up with Indian drug manufacturer Aurobindo Pharma to expand its portfolio of generic medicines in the US …

News

Sanofi cleared to buy Zentiva

February 11, 2009
Sales and Marketing Sanofi, generics

The European Commission says Sanofi-Aventis can go ahead with its planned acquisition of Czech generics company Zentiva. The Commission had …

News

Teva and Lonza join forces in biosimilars

January 21, 2009
Sales and Marketing biosimilars, generics

Teva, the world's largest generics manufacturer, has teamed up with manufacturing specialist Lonza to exploit the market for biosimilar medicines. …

News

Ratiopharm put up for sale after Merckle suicide

January 19, 2009
Sales and Marketing Teva, generics

German generics company Ratiopharm will be sold off following the death Adolf Merckle, its founder and chief executive. Merckle committed …

News

Preparing for the US generics boom

December 15, 2008
Sales and Marketing US, generics

One of Barack Obama's key goals as president is to reduce healthcare costs, particularly those related to prescription medications, by …

News

Cytotoxic therapies to feel sting of generics

December 8, 2008
Sales and Marketing generics

Cytotoxic therapy has been the cornerstone of cancer treatment for many years: indeed, despite a number of unpleasant side effects, …

News

Latest news from Datamonitor

November 17, 2008
Sales and Marketing biosimilars, generics

Key decision makers will shape the biosimilars landscapeWith many biologic drugs used to treat increasingly common diseases such as cancer …

News

Sanofi seals Zentiva deal with improved offer

September 23, 2008
Sales and Marketing MA, Sanofi, generics

Sanofi-Aventis' acquisition of Czech generics firm Zentiva is back on, after the pharma company increased its offer by nearly 10%. …

News

Giuliani to argue Ranbaxy’s case in US

September 18, 2008
Sales and Marketing US, generics

Indian generics firm Ranbaxy has hired former New York mayor Rudolf Giuliani to help reverse an FDA block on imports …

News

Danish court overturns Lipitor patent challenge

September 5, 2008
Sales and Marketing Denmark, Lipitor, Pfizer, generics

A court in Denmark has ruled in favour of Pfizer in challenges to patents on the active ingredient – atorvastatin …

News

Generics giant formed as Teva acquires Barr

July 24, 2008
Sales and Marketing generics

Teva is to buy rival firm Barr for $7.5 billion to create a new giant in the global generics industry. …

News

AstraZeneca wins vital Seroquel battle

July 3, 2008
Sales and Marketing AZ, generics, psych

Anglo-Swedish pharma company AstraZeneca has scored a vital victory in defending the patent on its blockbuster drug Seroquel. A US …

News

Latest content

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024

FDA approves Roche’s HPV self-collection screening option

May 15, 2024

NHS accepts Pfizer’s tafamidis for ATTR-CM treatment

May 14, 2024